Low body adiposity and high leptinemia in breast-fed infants born small-for-gestational-age

Lourdes Ibáñez1, Giorgia Sebastiani, Marta Diaz

  • 1Endocrinology Unit, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain. libanez@hsjdbcn.org

The Journal of Pediatrics
|December 17, 2009
PubMed

Insights

Breast-fed infants born small-for-gestational-age (SGA) had lower body fat but higher leptin levels in early infancy. This suggests a potential programming for later adult overweight in SGA infants.

Area of Science:

  • Pediatric endocrinology
  • Infant nutrition
  • Metabolic programming

Background:

  • Small-for-gestational-age (SGA) infants are at increased risk for metabolic complications.
  • Early life factors, including nutrition, significantly influence long-term health outcomes.
  • Adiposity and hormonal profiles in infancy may predict later metabolic health.

Purpose of the Study:

  • To investigate adiposity and leptin levels in breast-fed infants born small-for-gestational-age (SGA) compared to appropriate-for-gestational age (AGA) infants.
  • To explore the potential role of early infant hyperleptinemia in metabolic programming from fetal underweight to adult overweight.

Main Methods:

  • Comparison of adiposity measurements in breast-fed SGA infants (n=28) and AGA infants (n=46) during early infancy.
  • Measurement of circulating leptin levels at 4 months of age in both infant groups.

Main Results:

  • SGA infants exhibited lower adiposity compared to AGA infants.
  • SGA infants demonstrated significantly higher circulating leptin levels (2-fold increase, P < .001) at 4 months of age.
  • A paradoxical hyperleptinemia was observed in SGA infants despite lower adiposity.

Conclusions:

  • Early infancy adiposity and leptin levels differ between SGA and AGA infants.
  • Paradoxical hyperleptinemia in SGA infants may be an early marker for metabolic programming.
  • This programming could link fetal underweight to an increased risk of adult overweight.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...